Our current finding on age-associated elevation in TLR5-mediated immune responses offers novel opportunities for flagellin-related therapeutic uses and vaccines – a potentially powerful strategy to harness the innate immune system to address the increased susceptibility to infections and decreased response to vaccines in the elderly. This evidence concerns the gene TLR5 and infection.